Zacks: Brokerages Expect Blue Apron Holdings Inc (APRN) to Post -$0.22 EPS

Share on StockTwits

Wall Street brokerages expect that Blue Apron Holdings Inc (NYSE:APRN) will report ($0.22) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Blue Apron’s earnings, with the lowest EPS estimate coming in at ($0.23) and the highest estimate coming in at ($0.21). Blue Apron reported earnings per share of ($0.47) in the same quarter last year, which would indicate a positive year-over-year growth rate of 53.2%. The business is scheduled to announce its next earnings results on Thursday, November 1st.

On average, analysts expect that Blue Apron will report full-year earnings of ($0.72) per share for the current financial year, with EPS estimates ranging from ($0.76) to ($0.70). For the next financial year, analysts anticipate that the business will post earnings of ($0.53) per share, with EPS estimates ranging from ($0.71) to ($0.39). Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Blue Apron.

Blue Apron (NYSE:APRN) last posted its quarterly earnings data on Thursday, August 2nd. The company reported ($0.17) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.17). The business had revenue of $179.60 million during the quarter, compared to analyst estimates of $188.51 million. Blue Apron had a negative net margin of 24.64% and a negative return on equity of 89.80%. The company’s revenue was down 24.6% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.47) earnings per share.

A number of research firms have recently weighed in on APRN. Zacks Investment Research lowered shares of Blue Apron from a “buy” rating to a “hold” rating in a research report on Thursday, August 2nd. SunTrust Banks reissued a “hold” rating and issued a $2.70 price objective on shares of Blue Apron in a research report on Wednesday, May 9th. Barclays cut their price objective on shares of Blue Apron from $3.50 to $2.50 and set an “equal weight” rating for the company in a research report on Monday, August 6th. Morgan Stanley cut their price objective on shares of Blue Apron from $1.90 to $1.30 and set an “equal weight” rating for the company in a research report on Friday, August 3rd. Finally, ValuEngine raised shares of Blue Apron from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $3.95.

In related news, General Counsel Benjamin C. Singer sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 14th. The shares were sold at an average price of $3.05, for a total transaction of $30,500.00. Following the completion of the transaction, the general counsel now owns 15,940 shares of the company’s stock, valued at $48,617. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ilia M. Papas sold 133,333 shares of the company’s stock in a transaction that occurred on Thursday, June 7th. The stock was sold at an average price of $3.13, for a total transaction of $417,332.29. Following the transaction, the insider now directly owns 148,933 shares of the company’s stock, valued at approximately $466,160.29. The disclosure for this sale can be found here. Insiders have sold 568,510 shares of company stock valued at $1,725,364 in the last ninety days. 56.24% of the stock is currently owned by company insiders.

Hedge funds have recently modified their holdings of the stock. Dynamic Technology Lab Private Ltd acquired a new position in Blue Apron during the first quarter worth approximately $102,000. Goldman Sachs Group Inc. grew its stake in Blue Apron by 3,473.3% during the fourth quarter. Goldman Sachs Group Inc. now owns 76,878 shares of the company’s stock worth $310,000 after buying an additional 79,157 shares during the period. Bayesian Capital Management LP purchased a new stake in Blue Apron during the first quarter worth approximately $205,000. Teton Advisors Inc. purchased a new stake in Blue Apron during the first quarter worth approximately $225,000. Finally, Geode Capital Management LLC grew its stake in Blue Apron by 39.8% during the fourth quarter. Geode Capital Management LLC now owns 156,799 shares of the company’s stock worth $631,000 after buying an additional 44,602 shares during the period. 12.51% of the stock is owned by hedge funds and other institutional investors.

Shares of NYSE:APRN traded down $0.04 during trading on Friday, reaching $2.26. The stock had a trading volume of 7,091 shares, compared to its average volume of 4,329,193. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.74 and a quick ratio of 2.30. The firm has a market cap of $436.97 million, a PE ratio of -1.36 and a beta of -1.09. Blue Apron has a fifty-two week low of $1.72 and a fifty-two week high of $6.25.

About Blue Apron

Blue Apron Holdings, Inc operates an e-commerce marketplace that delivers original recipes and fresh ingredients for making home cooking accessible. It provides original recipes with the pre-portioned ingredients to complement tastes and lifestyles of college graduates, young couples, families, singles, and empty nesters.

Read More: What does RSI mean?

Get a free copy of the Zacks research report on Blue Apron (APRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Blue Apron (NYSE:APRN)

Receive News & Ratings for Blue Apron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Apron and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.